Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 245 articles:
HTML format



Single Articles


    May 2020
  1. POTTEGARD A, Hopfner F, Wod M, Hoglinger GU, et al
    Author response: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:899.
    PubMed    


  2. SCHERZER CR, Riise T, Locascio JJ
    Reader response: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:898-899.
    PubMed    


  3. SIEGLER JE 3RD, Galetta S
    Editors' note: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:897-898.
    PubMed    


  4. MAPPIN-KASIRER B, Pan H, Lewington S, Kizza J, et al
    Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.
    Neurology. 2020 May 5. pii: WNL.0000000000009437.
    PubMed     Abstract available


  5. CHENG Y, Wang YJ
    Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years.
    Neurology. 2020 May 5. pii: WNL.0000000000009431.
    PubMed    


    April 2020
  6. CAMACHO-SOTO A, Gross A, Searles Nielsen S, Miller AN, et al
    Fractures in the prodromal period of Parkinson disease.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009452.
    PubMed     Abstract available


  7. ARMSTRONG MJ, Emre M
    Dementia with Lewy bodies and Parkinson disease dementia: More different than similar?
    Neurology. 2020 Apr 24. pii: WNL.0000000000009433.
    PubMed    


  8. SMIRNOV DS, Galasko D, Edland SD, Filoteo JV, et al
    Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.
    Neurology. 2020 Apr 24. pii: WNL.0000000000009434.
    PubMed     Abstract available


  9. HUANG X, Gilbert GJ
    Psychosis in Parkinson disease: White matter matters.
    Neurology. 2020 Apr 21. pii: WNL.0000000000009368.
    PubMed    


  10. LENKA A, Ingalhalikar M, Shah A, Saini J, et al
    Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.
    Neurology. 2020 Apr 21. pii: WNL.0000000000009363.
    PubMed     Abstract available


  11. PONTONE GM, Mills KA
    A call for better depression treatment in people with Parkinson disease.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009285.
    PubMed    


  12. DOBKIN RD, Mann SL, Gara MA, Interian A, et al
    Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009292.
    PubMed     Abstract available


    March 2020

  13. Retraction: High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
    Neurology. 2020 Mar 30. pii: WNL.0000000000009358.
    PubMed    


  14. BORM CDJM, Visser F, Werkmann M, de Graaf D, et al
    Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire.
    Neurology. 2020 Mar 11. pii: WNL.0000000000009214.
    PubMed     Abstract available


  15. DEUSCHL G, Schuepbach MWM, Schade-Brittinger C, Tonder L, et al
    Author response: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:413.
    PubMed    


  16. SIDIROPOULOS C
    Reader response: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:412.
    PubMed    


  17. SIEGLER JE 3RD, Galetta S
    Editors' note: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:411-412.
    PubMed    


    February 2020
  18. ESPAY AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, et al
    Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
    Neurology. 2020 Feb 26. pii: WNL.0000000000009107.
    PubMed     Abstract available


  19. AHLSKOG JE
    Considerations for trials of disease modifying treatments in Parkinson disease.
    Neurology. 2020 Feb 26. pii: WNL.0000000000009127.
    PubMed    


  20. ZARKALI A, McColgan P, Leyland LA, Lees AJ, et al
    Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction.
    Neurology. 2020 Feb 24. pii: WNL.0000000000009014.
    PubMed     Abstract available


    January 2020
  21. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:144-145.
    PubMed    


  22. NELSON P
    Reader response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143-144.
    PubMed    


  23. SIEGLER JE 3RD, Galetta S
    Editors' note: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143.
    PubMed    


  24. WALDVOGEL D, Baumann-Vogel H, Stieglitz L, Hanggi-Schickli R, et al
    Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;94:39-41.
    PubMed    


    December 2019
  25. MISHRA VR, Sreenivasan KR, Yang Z, Zhuang X, et al
    Unique white matter structural connectivity in early-stage, drug-naive Parkinson disease.
    Neurology. 2019 Dec 27. pii: WNL.0000000000008867.
    PubMed     Abstract available


  26. CAMPBELL MC, Jackson JJ, Koller JM, Snyder AZ, et al
    Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008677.
    PubMed     Abstract available


  27. MAITI B, Koller JM, Snyder AZ, Tanenbaum AB, et al
    Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease.
    Neurology. 2019 Dec 17. pii: WNL.0000000000008754.
    PubMed     Abstract available


    November 2019
  28. ZHOU Z, Muller MLTM, Kanel P, Chua J, et al
    Apathy rating scores and beta-amyloidopathy in Parkinson disease patients at risk for cognitive decline.
    Neurology. 2019 Nov 15. pii: WNL.0000000000008683.
    PubMed     Abstract available


  29. HUGHES KC, Gao X, Molsberry S, Valeri L, et al
    Physical activity and prodromal features of Parkinson disease.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008567.
    PubMed     Abstract available


    October 2019

  30. Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019;93:725.
    PubMed    


  31. ABBOTT RD, Ross GW, Duda JE, Shin C, et al
    Excessive daytime sleepiness and topographic expansion of Lewy pathology.
    Neurology. 2019;93:e1425-e1432.
    PubMed     Abstract available


  32. SCHWARZSCHILD MA, Macklin EA, Bakshi R, Battacharyya S, et al
    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
    Neurology. 2019;93:e1328-e1338.
    PubMed     Abstract available


    September 2019
  33. URSO D, Monje MHG, Piredda R, Ortu R, et al
    Clinical Reasoning: A 58-year-old man with hand tremor and episodes of neck pain.
    Neurology. 2019;93:557-561.
    PubMed    


  34. MCCARTER SJ, Sandness DJ, McCarter AR, Feemster JC, et al
    REM sleep muscle activity in idiopathic REM sleep behavior disorder predicts phenoconversion.
    Neurology. 2019;93:e1171-e1179.
    PubMed     Abstract available


  35. SAVICA R
    Livin' on the edge: Risky behaviors and Parkinson disease: Genes, environment, or both?
    Neurology. 2019 Sep 16. pii: WNL.0000000000008236.
    PubMed    


  36. GROVER S, Lill CM, Kasten M, Klein C, et al
    Risky behaviors and Parkinson disease: A mendelian randomization study.
    Neurology. 2019 Sep 16. pii: WNL.0000000000008245.
    PubMed     Abstract available


  37. HIORTH YH, Pedersen KF, Dalen I, Tysnes OB, et al
    Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study.
    Neurology. 2019 Sep 16. pii: WNL.0000000000008314.
    PubMed     Abstract available


  38. CHAMORRO A, Mir P
    Raising serum urate levels in Parkinson disease: A strategy only for women?
    Neurology. 2019 Sep 4. pii: WNL.0000000000008191.
    PubMed    


    August 2019
  39. DEUEL L, Collins AE, Maa EH, Barr JP, et al
    Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system.
    Neurology. 2019 Aug 23. pii: WNL.0000000000008171.
    PubMed    


  40. LIN CH, Li CH, Yang KC, Lin FJ, et al
    Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2019 Aug 16. pii: WNL.0000000000008088.
    PubMed     Abstract available


  41. BOYLAN LS, Chio A
    Divining progression in Parkinson disease with a blood test: NfL.
    Neurology. 2019 Aug 16. pii: WNL.0000000000008087.
    PubMed    


  42. HWANG J, Bank AM, Mortazavi F, Oakley DH, et al
    Spinal cord alpha-synuclein deposition associated with myoclonus in patients with MSA-C.
    Neurology. 2019;93:302-309.
    PubMed     Abstract available


  43. BACKSTROM D, Domellof ME, Forsgren L
    Author response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed    


  44. KELLER DL
    Reader response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed    


  45. SIEGLER JE 3RD, Galetta S
    Editors' note: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:278.
    PubMed    


  46. SHIN JH, Park KW, Heo KO, Chung SJ, et al
    Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008053.
    PubMed     Abstract available


    July 2019
  47. YOON EJ, Ismail Z, Hanganu A, Kibreab M, et al
    Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.
    Neurology. 2019 Jul 18. pii: WNL.0000000000007968.
    PubMed     Abstract available


  48. BAIG F, Kelly MJ, Lawton MA, Ruffmann C, et al
    Impulse control disorders in Parkinson and RBD: A longitudinal study of severity.
    Neurology. 2019 Jul 16. pii: WNL.0000000000007942.
    PubMed     Abstract available


  49. LENKA A, Pagonabarraga J, Pal PK, Bejr-Kasem H, et al
    Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007913.
    PubMed     Abstract available


  50. LEE MJ, Pak K, Kim JH, Kim YJ, et al
    Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007939.
    PubMed     Abstract available


  51. BARICHELLA M, Cereda E, Pinelli G, Iorio L, et al
    Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2019 Jul 5. pii: WNL.0000000000007858.
    PubMed     Abstract available


    June 2019
  52. SHIRVAN J, Clement N, Ye R, Katz S, et al
    Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Neurology. 2019 Jun 26. pii: WNL.0000000000007855.
    PubMed     Abstract available



  53. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019;92:1166.
    PubMed    


  54. GERA A, Witek N, Bailey M
    Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
    Neurology. 2019;92:1116-1118.
    PubMed    


    May 2019
  55. HOPFNER F, Wod M, Hoglinger GU, Blaabjerg M, et al
    Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2019 May 24. pii: WNL.0000000000007694.
    PubMed     Abstract available


  56. PONTONE GM, Koch G
    An association between bipolar disorder and Parkinson disease: When mood makes you move.
    Neurology. 2019 May 22. pii: WNL.0000000000007641.
    PubMed    


  57. HUANG MH, Cheng CM, Huang KL, Hsu JW, et al
    Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.
    Neurology. 2019 May 22. pii: WNL.0000000000007649.
    PubMed     Abstract available


  58. GIANNINI G, Francois M, Lhommee E, Polosan M, et al
    Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.
    Neurology. 2019 May 17. pii: WNL.0000000000007665.
    PubMed     Abstract available


  59. ALONSO-NAVARRO H, Garcia-Martin E, Agundez JAG, Jimenez-Jimenez FJ, et al
    Association between restless legs syndrome and other movement disorders.
    Neurology. 2019;92:948-964.
    PubMed     Abstract available


  60. DE PABLO-FERNANDEZ E, Warner T
    Author response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925-926.
    PubMed    


  61. LAI SW
    Reader response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925.
    PubMed    


  62. GANESH A, Galetta S
    Editors' note: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:924.
    PubMed    


  63. LAU B, Meier N, Serra G, Czernecki V, et al
    Axial symptoms predict mortality in patients with Parkinson disease with subthalamic stimulation.
    Neurology. 2019 May 1. pii: WNL.0000000000007562.
    PubMed     Abstract available


    April 2019

  64. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:871.
    PubMed    


  65. KLEPITSKAYA O
    Author response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:869.
    PubMed    


  66. MARQUES AR, Fantini ML, Durif F
    Reader response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868-869.
    PubMed    


  67. GANESH A, Galetta S
    Editors' note: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868.
    PubMed    


  68. TUCK KK, Tarolli CG
    Palliative care and advance care planning in Parkinson disease.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007555.
    PubMed    


  69. NARENDRA DP, Isonaka R, Nguyen D, Schindler AB, et al
    Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007614.
    PubMed    


  70. LUM HD, Jordan SR, Brungardt A, Ayele R, et al
    Framing advance care planning in Parkinson disease: Patient and care partner perspectives.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007552.
    PubMed     Abstract available


  71. FORREST SL, Crockford DR, Sizemova A, McCann H, et al
    Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Neurology. 2019 Apr 24. pii: WNL.0000000000007530.
    PubMed     Abstract available


  72. JOST WH, Friedman A, Michel O, Oehlwein C, et al
    SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.
    Neurology. 2019;92:e1982-e1991.
    PubMed     Abstract available


  73. BOUGEA A, Maraki MI, Yannakoulia M, Stamelou M, et al
    Higher probability of prodromal Parkinson disease is related to lower cognitive performance.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007453.
    PubMed     Abstract available


    March 2019
  74. TRENKWALDER C, Kuoppamaki M, Vahteristo M, Muller T, et al
    Increased dose of carbidopa with levodopa and entacapone improves "off" time in a randomized trial.
    Neurology. 2019;92:e1487-e1496.
    PubMed     Abstract available


  75. YOO HS, Chung SJ, Lee YH, Lee HS, et al
    Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Neurology. 2019;92:e1468-e1478.
    PubMed     Abstract available


  76. CONNOR KI, Cheng EM, Barry F, Siebens HC, et al
    Randomized trial of care management to improve Parkinson disease care quality.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007324.
    PubMed     Abstract available


  77. CALABRESI P, Nigro P, Schwarz HB
    A nurse-led model increases quality of care in Parkinson disease.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007295.
    PubMed    


  78. BUCHMAN AS, Yu L, Wilson RS, Leurgans SE, et al
    Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies.
    Neurology. 2019 Mar 20. pii: WNL.0000000000007315.
    PubMed     Abstract available


  79. METZER WS, Rodrigues FB
    Managing treatment fluctuations in Parkinson disease: "On" again-, "off" again.
    Neurology. 2019 Mar 1. pii: WNL.0000000000007193.
    PubMed    


    February 2019
  80. AKHTAR RS, Mano T
    High serum neurofilament light chain predicts a worse fate in early parkinsonism.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007194.
    PubMed    


  81. MARQUES TM, van Rumund A, Oeckl P, Kuiperij HB, et al
    Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007179.
    PubMed     Abstract available


  82. CHUNG SJ, Bae YJ, Jun S, Yoo HS, et al
    Dysautonomia is associated with structural and functional alterations in Parkinson disease.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007181.
    PubMed     Abstract available


  83. VIDENOVIC A, Messinis L
    Enlightened PD: A novel treatment for Parkinson disease?
    Neurology. 2019 Feb 15. pii: WNL.0000000000007078.
    PubMed    


  84. RUTTEN S, Vriend C, Smit JH, Berendse HW, et al
    Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2019 Feb 15. pii: WNL.0000000000007090.
    PubMed     Abstract available


  85. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    PubMed     Abstract available


  86. CHEN CC
    Is outcome of subthalamic nucleus deep brain stimulation in Parkinson disease predictable?
    Neurology. 2019 Feb 8. pii: WNL.0000000000007023.
    PubMed    


  87. SCHUEPBACH WMM, Tonder L, Schnitzler A, Krack P, et al
    Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019 Feb 8. pii: WNL.0000000000007037.
    PubMed     Abstract available


    December 2018
  88. PRANGE S, Danaila T, Laurencin C, Caire C, et al
    Age and time course of long-term motor and nonmotor complications in Parkinson disease.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006737.
    PubMed     Abstract available


    November 2018
  89. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Abstract available


  90. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Abstract available


  91. KARCESKI S
    Parkinson disease and mortality: Understanding how the two are connected.
    Neurology. 2018;91:e2106-e2108.
    PubMed    


  92. KOO BB
    Author response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1030.
    PubMed    


  93. BRUNO V, Mancini D, Zurowski M, Miyasaki JM, et al
    Reader response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed    


  94. GANESH A, Galetta S
    Editors' note: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed    


  95. BLEDSOE IO, Stebbins GT, Merkitch D, Goldman JG, et al
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006646.
    PubMed     Abstract available


  96. TURCANO P, Mielke MM, Bower JH, Parisi JE, et al
    Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006643.
    PubMed     Abstract available


    October 2018
  97. GOLBE LI, Leyton CE
    Life expectancy in Parkinson disease.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006560.
    PubMed    


  98. BACKSTROM D, Granasen G, Domellof ME, Linder J, et al
    Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006576.
    PubMed     Abstract available


  99. FERRAYE MU
    Author response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:811.
    PubMed    


  100. VAN GERPEN JA, Tipton PW, Uitti RJ
    Reader response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810-811.
    PubMed    


  101. KARAM C, Galetta S
    Editors' note: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810.
    PubMed    


  102. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed    


  103. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed    


  104. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed    


  105. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Abstract available


    September 2018
  106. MORENO GM, Gandhi R, Lessig SL, Wright B, et al
    Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006396.
    PubMed    


    August 2018
  107. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Abstract available


  108. ZERVOS TM, Hamani C, Schwalb JM
    MRIgFUS in tremor-dominant PD does not lead to substantial cognitive adverse events.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006268.
    PubMed    


  109. ADAMS JL, La Morgia C
    The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
    PubMed    


  110. AHN J, Lee JY, Kim TW, Yoon EJ, et al
    Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
    PubMed     Abstract available


  111. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Abstract available


  112. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
    PubMed     Abstract available


  113. MACLEOD AD, Myint PK, Counsell CE
    Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:287.
    PubMed    


  114. MARINELLI L
    Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed    


  115. ALCAUSKAS M, Galetta S
    Editors' note: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed    


  116. THOMPSON T, Poulter D, Miles C, Solmi M, et al
    Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2018 Aug 3. pii: WNL.0000000000006132.
    PubMed     Abstract available


    July 2018
  117. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed    


  118. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed    


  119. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed    


  120. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed    


  121. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed    


  122. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed    


  123. FERRER P
    Author response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:192.
    PubMed    


  124. BHATTACHARJEE S
    Reader response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191-192.
    PubMed    


  125. ALCAUSKAS M, Galetta S
    Editors' note: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191.
    PubMed    


  126. FIRBANK MJ, Parikh J, Murphy N, Killen A, et al
    Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006007.
    PubMed     Abstract available


  127. ONOFRJ M, Gilbert GJ
    GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
    Neurology. 2018 Jul 18. pii: WNL.0000000000005985.
    PubMed    


  128. SEARLES NIELSEN S, Racette BA
    Author response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed    


  129. KAWADA T
    Reader response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed    


  130. ALCAUSKAS M, Galetta S
    Editors' note: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:103.
    PubMed    


  131. NONNEKES J, Bloem BR
    Deliberate gait scissoring to overcome freezing of gait in Parkinson disease.
    Neurology. 2018;91:97.
    PubMed    


    June 2018
  132. HACKER ML, DeLong MR, Turchan M, Heusinkveld LE, et al
    Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005903.
    PubMed     Abstract available


  133. CORVOL JC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Longitudinal analysis of impulse control disorders in Parkinson disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005816.
    PubMed     Abstract available


  134. DE PABLO-FERNANDEZ E, Goldacre R, Pakpoor J, Noyce AJ, et al
    Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005771.
    PubMed     Abstract available


    May 2018
  135. CHEN H
    Author response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:941.
    PubMed    


  136. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Reader response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed    


  137. ALCAUSKAS M, Galetta S
    Editors' note: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed    


  138. BOOT E, Butcher NJ, Udow S, Marras C, et al
    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Neurology. 2018 May 11. pii: WNL.0000000000005660.
    PubMed     Abstract available


  139. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Abstract available


  140. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed    


    April 2018
  141. FERREIRA JJ, Lees AJ, Poewe W, Rascol O, et al
    Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005557.
    PubMed     Abstract available


  142. FULLARD ME, Willis AW
    Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:813.
    PubMed    


  143. BRYANT MS, Protas EJ
    Reader response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed    


  144. KARAM C, Galetta S
    Editors' note: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed    


  145. GARDNER RC, Byers AL, Barnes DE, Li Y, et al
    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study.
    Neurology. 2018 Apr 18. pii: WNL.0000000000005522.
    PubMed     Abstract available


  146. ROOS E, Grotta A, Yang F, Bellocco R, et al
    Body mass index, sitting time, and risk of Parkinson disease.
    Neurology. 2018;90:e1413-e1417.
    PubMed     Abstract available


  147. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Abstract available


  148. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Abstract available


  149. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed    


  150. BARRETT MJ, Blair JC, Sperling SA, Smolkin ME, et al
    Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005421.
    PubMed     Abstract available


  151. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Abstract available


  152. BOHNEN NI, Teipel SJ
    Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005408.
    PubMed    


    March 2018
  153. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed    


  154. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed    


  155. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Abstract available


  156. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed    


  157. BRODSKY M, Lahna D, Pollock J, Pettersson D, et al
    Nigrosome 1 absence in de novo Parkinson disease.
    Neurology. 2018;90:522-523.
    PubMed    


    February 2018
  158. DIRKX MF, Zach H, Bloem BR, Hallett M, et al
    The nature of postural tremor in Parkinson disease.
    Neurology. 2018 Feb 23. pii: WNL.0000000000005215.
    PubMed     Abstract available


  159. HASSAN A
    No handshake agreement on postural tremor subtypes in Parkinson disease?
    Neurology. 2018 Feb 23. pii: WNL.0000000000005199.
    PubMed    


  160. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Abstract available


  161. WEISS D, Massano J
    Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005111.
    PubMed    


  162. ARLOTTI M, Marceglia S, Foffani G, Volkmann J, et al
    Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005121.
    PubMed     Abstract available


  163. HONMA M, Masaoka Y, Kuroda T, Futamura A, et al
    Impairment of cross-modality of vision and olfaction in Parkinson disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005110.
    PubMed     Abstract available


    January 2018
  164. MURATA M, Odawara T, Hasegawa K, Iiyama S, et al
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005010.
    PubMed     Abstract available


  165. HERSHEY LA, Irwin DJ
    Zonisamide for DLB parkinsonism: An old drug used in a new context.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005006.
    PubMed    


  166. LEE PC, Ahmed I, Loriot MA, Mulot C, et al
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology. 2018 Jan 19. pii: WNL.0000000000004953.
    PubMed     Abstract available


  167. DAVIS JL, Kurek JA, Morgan JC, Sethi KD, et al
    Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.
    Neurology. 2018;90:e263.
    PubMed    


  168. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed    


  169. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Abstract available


    December 2017
  170. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Abstract available


  171. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Abstract available


  172. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Abstract available


  173. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed    


  174. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Abstract available


  175. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Abstract available


    November 2017
  176. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed    


  177. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed    


  178. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed    


  179. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Abstract available


    October 2017
  180. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Abstract available


  181. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Abstract available


  182. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Abstract available


  183. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed    


  184. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Abstract available


  185. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed    


    September 2017
  186. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Abstract available


  187. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed    


  188. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Abstract available


  189. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed    


  190. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Abstract available


  191. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Abstract available


  192. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Abstract available


  193. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Abstract available


  194. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed    


  195. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Abstract available


  196. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Abstract available


    August 2017
  197. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Abstract available


  198. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Abstract available


  199. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed    


  200. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Abstract available


  201. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed    


  202. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Abstract available


    July 2017
  203. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed    


  204. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Abstract available


  205. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed    


  206. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Abstract available


  207. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Abstract available


  208. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Abstract available



  209. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed    


    June 2017
  210. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Abstract available


  211. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Abstract available


    May 2017
  212. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Abstract available


  213. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Abstract available


    April 2017
  214. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Abstract available


  215. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed    


    March 2017
  216. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Abstract available


  217. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed    


  218. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Abstract available


  219. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Abstract available


  220. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed    


  221. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Abstract available


    February 2017
  222. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed    


  223. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed    


  224. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed    


  225. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed    


  226. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Abstract available


  227. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Abstract available


  228. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Abstract available


  229. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed    


  230. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Abstract available


    January 2017
  231. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Abstract available


  232. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Abstract available


  233. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Abstract available


  234. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Abstract available


    December 2016
  235. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Abstract available


  236. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed    


  237. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Abstract available


    November 2016
  238. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Abstract available


  239. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed    


  240. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed    


  241. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Abstract available


  242. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Abstract available


    October 2016
  243. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Abstract available


  244. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Abstract available


    September 2016
  245. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: